NMDA receptor drugs for Major Depressive Disorder

10 tracked NMDA receptor drugs in the Major Depressive Disorder race. The class explanation lives on the NMDA receptor page; the full indication pipeline across every mechanism is on the Major Depressive Disorder page.

1 approved / phase 47 Phase 22 Phase 1

Head-to-head evidence: ACP-211 vs ALA-3000 · ACP-211 vs AV-101 · ACP-211 vs BI 1569912 · ACP-211 vs Blixeprodil · ACP-211 vs Esketamine · ACP-211 vs Esketamine (CLE-100)

The roster

← all NMDA receptor drugs